Xiangshu Xiao, Ph.D.
Xiangshu received his B.S. from then Beijing Medical University (now Peking University Health Science Center). He then joined a master graduate program at Shanghai Institute of Materia Medica in Chinese Academy of Sciences. In 2001, he joined Purdue University as a Ph.D. student. He was a postdoctoral fellow at UT Southwestern Medical Center from 2005-2007 and joined OHSU faculty in 2007.Link to CV
Bingbing LI, M.D., Ph.D.
Bingbing got her M.D. in 1998 from Henan Medical University, Zhengzhou, China. Realizing her great interest in basic research, she went to Shanghai Medical College of Fudan University to pursue a Master degree in Genetics. In 2002, she was accepted into the genetics graduate program at Purdue University in 2002 and joined Don Ready lab in 2003. Her thesis was to study the function of MyoV in Drosophila eye development (rhabdomere development) and photoreceptor pigment granule movement. Inspired by the book "Racing to the Beginning of the Road: The Search for the Origin of Cancer" by Bob Weinberg, she got interested in cancer research. So she joined Xianghsu Xiao's lab and has been working on the pharmacology and mechanism of action of novel anti-cancer compounds. She has two daughters and all her free time is theirs. Still she tries to find time to read all kinds of books.
Fuchun Xie, Ph.D.
Fuchun received his B.S. degree from Anhui University and then his PhD in medicinal chemistry from Shanghai Institute of Materia Medica, Chinese Academy of Sciences, China. He started postdoc training at OHSU in 2010. His project is mainly focused on the design, synthesis and evaluation of small molecules targeting CREB-mediated gene transcription to treat breast cancer.Publications
Bo Chao, Ph.D.
Bo obtained his Ph. D. from Shanghai Institute of Materia Medica, Chinese Academy of Sciences. He joined Xiangshu Xiao's lab as a postdoctoral researcher in 2013. His current work is the design and optimization of novel anticancer compounds.